Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Femoral Peri-arterial Injection for Tourniquet Hypertension
NCT03390426Phase 4Completed
- Sponsor
- Duke University
- Start
- May 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mepivacaine in hypertension (HTN), sponsored by Duke University. Started May 2018; status: completed.
02
Drugs
mepivacaine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03390426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390426.